å·«å±±æ¯ããªïŒãã©ãã°ïŒå·«å±±æ¯ããªïŒð¢ ðºðžã§ã¯æ°å¹Žããªããªã€ã系麻è¬(ã±ã·è£œ)ãã§ã³ã¿ãã«ã§èšå€§ãªæ°ã®æ»è ãåºãã18ã49æ³æ»äº¡åå äžäœã¯ãã§ã³ã¿ãã«ãã¢ã«ããã®100å匷åãšèšãããŠããã ããã®100å匷åãªã«ã«ãã§ã³ã¿ãã«ãåºåãå§æ«ã èŽæ»éã¯ããã€ã³30ã100mgããã§ã³ã¿ãã«2mgãã«ã«ãã§ã³ã¿ãã«0.02mgã 颚ã§èãäžãã£ã麻è¬ãææ»å®ãåžã蟌ãã ãã§èŽæ»ãäŸåã«äŸµãããã æ ã«ã¢ã¡ãªã«æ¿åºã麻è¬ãšã®æŠãã®æ¿çãæã¡åºããã ãã§ã³ã¿ãã«æ®æè¬ããããœã³ããæãã§ã³ã¿ãã«ã¯ã¯ãã³ãªã©ã䜿çšãããå§æ«ã
4/1ããæ°åã³ãã æ²»çè¬å ¬è²»è£å©ãªããªããŸãã 3å²è² æ 㧠ã»ãŸã³ãŒããçŽ15000å (7æ¥) ã»ã©ã²ããªãªãçŽ20000å (5æ¥) ã»ãã¯ã«ãªãŒç¹æ»ŽãçŽ100000å (4~6æ¬) ã»ã¯ã¯ãã³ãçŽ7000å ã»å ¥é¢è£å©ãªã è¬ã¯ã³ããåŸéºçã§ã䜿çšãããŠãã®ã§ããã€ã èŸãå Žåã¯åŸéºçå¿é ãªã®ã§ãæ²»çè¬éžæãã å ã¿ã«ãæææè 垯ã¯10æ³æªæºãäžåã®é£ç¶äžäœã ãã®å¹Žä»£ã®åäŸã«äœ¿ããæãŠã€ã«ã¹è¬ãç¡ããã§ãããâŠ(12æ³ãã) è³ãŸã§è¡ãã®åãã£ãŠãŸããããã¯ã¯ãã³ã§é²åŸ¡ããŠãã ãããšããã åŸæããŠããã§ã¯é ãã§ãããã埡æ€èšãã
COVID-19ããç¥çµçŽ°èâïžã¢ã¹ãããµã€ãâïžè¡ç®¡ã®æ é€ãªã©ã®ããåããããŠããéšäœã«çµå â Neurovascular coupling impairment (ç¥çµè¡ç®¡çµåé害)ãèªå° âæ é€äžè¶³ãªã©ããèšæ¶é害ãèªå° ãå€æãç¥çµè¡ç®¡çµåéšã®ãŠã€ã«ã¹é€å»ã§èšæ¶é害ãæ²»ãå¯èœæ§ã Brain Communications 2024幎3æ7æ¥ academic.oup.com/braincomms/a...
ããã§ããã çãšäžæ¬ãã«ãããŸãããã§ããèåšãéšäœã«ãã£ãŠãç¹åŸŽã¯å€çš®å€æ§ã§ãã èå现èãéã«çåé²æ¢ããŠãããªã©ãè¿å¹Žã®ã³ãããèåç 究ãããæ°ããªäºå®ãåãã£ãŠããŠããŸãã ãããã®ç¥èããäœãšãçæ²»çã«æå¹æŽ»çšã§ããã°ãªãâŠãšã®æãã§ãã é 匵ããŸãã
ãããã€âŠãªããšãè¬ãåºæ¥ãããšãç¥ããŸã
ç±³åœæ¿èªã®ALSæ²»çè¬ãæ²»éšã§å€±æã販売åæ¢æ€èš - æ¥æ¬çµæžæ°è www.nikkei.com/article/DGXZ...
ããã¥ãŒãšãŒã¯=åç°åç¹ãç±³ãã€ãªãã³ãã£ãŒãã¢ããªãã¯ã¹ã»ãã¡ãŒãã·ã¥ãŒãã£ã«ã«ãºã¯11æ¥ãŸã§ã«ãåŸã ã«çèãåããããšãã§ããªããªãé£ç ãALSïŒçèçž®æ§åŽçŽ¢ç¡¬åçïŒæ²»çè¬ã«ã€ããŠãæçµæ®µéãšãªã第3çžèšåºè©ŠéšïŒæ²»éšïŒã倱æãããšçºè¡šãããä»åŸ8é±é以å ã«è²©å£²åæ¢ãããã決ãããšæããã«ãããã¢ããªãã¯ã¹ã¯åœåãçµå£è¬ãã¬ãªããªãªãã¯ALSã®é²è¡ãé ãããŠãæ£è ã®å¯¿åœãçŽ10ã«æ延ã°ãããš
ç现èã®å ç«åé¿ã¯ ã»çæåç©è³ªé ã ã»å ç«æå¶ç©è³ªæŸåº ã»å ç«ãã§ã ããã€ã³ã(ãã¬ãŒã)ã·ã°ãã«æ瀺 ãªã©ãããŸãã ã³ããã¯äž»ã« ã»æåç©è³ªé ã ã»å€ç°ã«ããæ·±å»ãªå ç«å·ã蟌㿠ã»å¡äœã£ãŠãããããŠã€ã«ã¹ãæžãã ã§ãã çã«å¯Ÿããã¯ã¯ãã³ã¯éååããå®éšãããŠããã ã»ç现èã«æäœã§æšçä»äžâå ç«çŽ°èã§æ»æ ãªã©ãè²ã ãããŸããã ä»ãå ç«æŽ»æ§åããããªããžãŒã(2018幎ããŒãã«è³)ãããã«è¿ãã§ãã ã¢ã€ãã¢ã¯ãã³ãã³å ·çŸåãããŠãã£ãŠãã ãããïŒãããéãéããŸãïŒ ïœžïŸïœ¯! ( *ËË*)Ù
æ°åã³ãããªãã¯ãã³æ ªã®å ç«åé¿ å€ç°ã«ããnAb ã«ããäžåãäœäžãäžéšã® T 现èã®æŽ»æ§åäœäžã æåå眪ã¯ãªãã¯ãã³å€ç°äœã«ããåææãèªåŒãæŠæŒ¢ Hu-1 æ ªæææ£è ã¯æãªãã¯ãã³äžåæäœãšT 现èã®åå¿äžæããªãæ·±å»ãªå·ã蟌ã¿å¹æã ææè æ»äº¡çã¯ãå£ç¯æ§ã€ã³ãã«ãšã³ã¶æ¯èŒãæ»äº¡ççŽ 7 ïœ 8 åã§80æ³ä»¥äžã®é«éœ¢è ã¯10ïŒ ä»¥äžãã€ã³ãã«ãšã³ã¶æ»äº¡çãã100 åé«ãã 察åŠæ³ã¯ãªãã¯ãã³å€ç°ã»éçåæå¶ãå¿ èŠã§å ¬è¡è¡çãã¯ã¯ãã³ã§ã®æŒãã蟌ã¿ãå¿ èŠã Front. Immunol 2024/2/23 www.frontiersin.org/journals/imm...
ããã®#ããŒã¯æŒããšããã£ãŒã«ãéžã¹ãã®ã§ã絵垫ããå士ã«ã¯äŸ¿å©ãªã®ããã
絵垫ããå€ããŠå¹³åã§ããã
"SYNCYTIA"æ°åã³ããã®åéäœã»åèäœ æ°åã³ããã¯åéäœã»åèäœãææçµç¹ã§äœãç æ°ã®è延ãšéçåä¿é²ããã«ã¿äºçš®ããã§ç¢ºèªã ã»ãŠã€ã«ã¹èèçœå解é»å®³âå®å®æ§â ã»é«å±ææ¿åºŠâæšç现èãžã®çµåã»äŸµå ¥â ã»çŽ°èå ã§ã®è€è£œãææã¬ãã«â ã»é£æ¥çŽ°èãšèåãå ç«çŽ°èããéé¿â ã»çŽ°èã®èåâçµç¹ã®æ©èœç Žå£âèåšäžå šâéçå www.biorxiv.org/content/10.1...www.sciencedirect.com/science/arti...